Zeto

Executive Summary

Zeto Inc. is a San Jose-based medical device company that has developed an FDA-approved, portable, wireless EEG headset with dry electrodes, enabling rapid point-of-care brain monitoring without conductive gel or specialized technicians. The system integrates real-time remote monitoring, live video, and AI-powered seizure detection, making it suitable for hospital ICUs and emergency departments. Founded in 2013, Zeto addresses a critical need for faster, more accessible EEG diagnostics, potentially reducing time-to-treatment for conditions like status epilepticus. The company is currently in Phase 1, indicating early commercialization and revenue generation.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for expanded indications (e.g., pediatric or ICU-specific use)70% success
• Q2 2027Key hospital system partnership or group purchasing organization (GPO) contract50% success
• Q3 2026Publication of clinical outcomes data demonstrating improved time-to-diagnosis or seizure detection accuracy60% success